Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Androgens are thought to play a role in the pathogenesis of prostate cancer. We evaluated androgen levels in 3 age‐matched groups of men who were part of the Baltimore Longitudinal Study of Aging: 1) 16 men with no prostatic disease by urologic history and exam (control group); 2) 20 men with a histologic diagnosis of benign prostatic hyperplasia (BPH) who had undergone simple prostatectomy; and 3) 20 men with a histologic diagnosis of prostate cancer (16 with local/regional cancer, and 4 with metastatic cancer). Luteinizing hormone (LH), total testosterone (T), and free T were measured on stored AM sera by radioimmunoassay (RIA). Free T was also calculated from the measured concentrations of total T and sex hormone binding globulin (SHBG). The median number of repeated sex steroid measurements ranged from 6–9 over a period from 7–25 years prior to the diagnosis of prostate disease. There were no significant differences in age‐adjusted LH, total T, SHBG, or calculated free T levels among the groups at 0–5, 5–10, and 10–15 years before diagnosis. These data suggest that there are no measurable differences in serum testosterone levels among men who are destined to develop prostate cancer and those without the disease. © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Södergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080
Cited by
Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
Hormones, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm323 · Cited by 786
Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden, E. L., & Morgentaler, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022251 · Cited by 705
Andropause: clinical implications of the decline in serum testosterone levels with aging in men
Matsumoto, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.2.m76 · Cited by 490
“Most (368,369,437) but not all (371,438,439) descriptive studies have failed to find a significant relationship between endogenous T levels and the development of BPH or prostate cancer.”
BackgroundKenny, A. M., Prestwood, K. M., Gruman, C. A., Marcello, K. M., & Raisz, L. G. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.m266 · Cited by 456
The benefits and risks of testosterone replacement therapy: a review
Morley, J. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3025 · Cited by 369
Allen, C. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00200-x · Cited by 352
High‐grade prostate cancer is associated with low serum testosterone levels
Schatzl, G., Madersbacher, S., Thurridl, T., Waldmüller, J., Kramer, G., Haitel, A., & Marberger, M. (2001) · The Prostate · doi:10.1002/pros.1046 · Cited by 334
IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?
HOFFMAN, M. A., DeWOLF, W. C., & MORGENTALER, A. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67812-3 · Cited by 322
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
Bosland, M. C. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024244 · Cited by 307
Reproductive ecology and life history of the human male
Bribiescas, R. G. (2001) · American Journal of Physical Anthropology · doi:10.1002/ajpa.10025 · Cited by 273
Platz, E. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2009 · Cited by 255
Testosterone for the aging male; current evidence and recommended practice
Jones, H. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s190 · Cited by 204
“Most longitudinal studies have not shown a correlation between testosterone levels and the future development of prostate cancer (Carter et al 1995; Heikkila et al 1999; Stattin et al 2004) but a recent study did fi nd a positive association (Parsons et al 2005). by TCPDF (www.tcpdf.org)”
Platz, E. A., & Giovannucci, E. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.002 · Cited by 180
Metadata
- Authors
- Carter, H. B., Pearson, J. D., Metter, E. J., Chan, D. W., Andres, R., Fozard, J. L., Rosner, W., & Walsh, P. C.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 1995-07
- Volume
- 27
- Issue
- 1
- Pages
- 25-31
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W1988261420
- Cited by
- 142
- References
- 1
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.